SCHEMBL7964170

SCHEMBL7964170

CC(C)c1ccc(C(=O)Nc2ccc3ccccc3c2)cc1

nearest known ligand 0.73

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 14/20 0.73
NPC1 O15118 13/20 0.73
MEN1 O00255 8/20 0.73
KMT2A Q03164 8/20 0.73
TDP1 Q9NUW8 1/20 0.73
CASP3 P42574 5/20 0.61
SENP7 Q9BQF6 5/20 0.61
SENP6 Q9GZR1 3/20 0.61
SENP8 Q96LD8 2/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
NQO2 P16083 1/20 0.60
DEGS1 O15121 1/20 0.57
KDM4E B2RXH2 2/20 0.57
LMNA P02545 1/20 0.57
SMN1; SMN2 Q16637 3/20 0.56
GAA P10253 1/20 0.56
ALDH1A1 P00352 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3503370 0.89 NPC1 (0.84) RAB9ANPC1MEN1KMT2ATDP1
SCHEMBL8420152 0.84 NPC1 (0.72) RAB9ANPC1MEN1KMT2ATDP1
SCHEMBL2681024 0.84 NPC1 (1.00) RAB9ANPC1MEN1KMT2ATDP1
SCHEMBL2230642 0.84 NPC1 (0.77) RAB9ANPC1MEN1KMT2ATDP1
SCHEMBL26885202 0.84 NPC1 (0.77) RAB9ANPC1MEN1KMT2ATDP1
SCHEMBL2229842 0.84 NPC1 (0.76) RAB9ANPC1MEN1KMT2ATDP1
SCHEMBL23844169 0.84 LMNA (0.76) RAB9ANPC1MEN1KMT2ATDP1
SCHEMBL8081011 0.83 DEGS1 (0.82) RAB9ANPC1MEN1KMT2ATDP1
SCHEMBL3660083 0.83 NPC1 (0.74) RAB9ANPC1MEN1KMT2ATDP1
SCHEMBL13863923 0.83 MEN1 (0.71) RAB9ANPC1MEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218393-B1 IN THERAPY OF MULTIDRUG RESISTANT CANCERS, FOR EXAMPLE TO POTENTIATE CYTOTOXICITY OF CANCER DRUG XENOVA LIMITED (GB) 2001-04-17 US disclosed